Differential substrate specificity of rabbit OCT1 and OCT2

被引：0
|
作者：
Kaewmokul, S
Chatsudthipong, V
Wright, SH
机构：
[1] Univ Arizona, Coll Med, Tucson, AZ 85724 USA
[2] Mahidol Univ, Bangkok 10700, Thailand
来源：
FASEB JOURNAL | 2002年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A459 / A459
页数：1
相关论文
共 50 条
  • [21] Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2)
    Peng Zhu
    Zhi Ye
    Dong Guo
    Zongping Xiong
    Shiqiong Huang
    Jun Guo
    Wei Zhang
    James E. Polli
    Honghao Zhou
    Qing Li
    Yan Shu
    Pharmaceutical Research, 2018, 35
  • [22] Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake
    Choi, Min-Koo
    Song, Im-Sook
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2012, 33 (03) : 170 - 178
  • [23] The organic cation transporters OCT1 and OCT2 contain an allosteric cation inhibitor site.
    Koepsell, H
    UlzheimerTeuber, I
    Ulzheimer, J
    Arndt, P
    Gorboulev, V
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0259 - A0259
  • [24] Inhibitory interaction of 125 frequently prescribed drugs with the organic cation transporters OCT1 and OCT2
    Muench, K.
    Zolk, O.
    Monti, J.
    Maas, R.
    Fromm, M. F.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S58 - S58
  • [25] Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin
    Eriko Shikata
    Rei Yamamoto
    Hiroshi Takane
    Chiaki Shigemasa
    Tadasu Ikeda
    Kenji Otsubo
    Ichiro Ieiri
    Journal of Human Genetics, 2007, 52 : 117 - 122
  • [26] Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin
    Shikata, Eriko
    Yamamoto, Rei
    Takane, Hiroshi
    Shigemasa, Chiaki
    Ikeda, Tadasu
    Otsubo, Kenji
    Ieiri, Ichiro
    JOURNAL OF HUMAN GENETICS, 2007, 52 (02) : 117 - 122
  • [27] Of dogs and men: Cloning of dog OCT1 and OCT2 and comparative characterization with human and other known orthologs
    Falk, S.
    Meyer, M. J.
    Roemer, S.
    Geyer, J.
    Simm, S.
    Tzvetkov, M. V.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (SUPPL 1) : S46 - S47
  • [28] Inhibition of human OCT1, OCT2, MATE1, OAT1 and NTCP mediated uptake by pesticides
    Kuehne, A.
    Floerl, S.
    Halpape, R.
    Hagos, Y.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S72 - S73
  • [29] PARA-AMINOSALYCYLIC ACID (PAS) CHARACTERIZED AS A SUBSTRATE OF OCT1 AND OCT2 AND OAT1 AND OAT3 TRANSPORTER, IN VITRO.
    Masud, P. Md.
    Jung, J.
    Choi, H.
    Shin, H.
    Kim, D.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S97 - S97
  • [30] Analysis of OCT1, OCT2 and OCT3 gene polymorphisms among Type 2 diabetes mellitus subjects in Indian ethnicity, Malaysia
    Al-Ashoor, Sabah Ghasan Abood
    Ramachandran, Vasudevan
    Mat, Liyana Najwa Inche
    Mohamad, Nur Afiqah
    Mohamed, Mohd Hazmi
    Sulaiman, Wan Aliaa Wan
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2022, 29 (01) : 453 - 459
12345